Home » Newsletters » BioWorld Science

BioWorld Science

June 28, 2006

View Archived Issues

Studies delineate armodafinil effects in patients with sleep disorders

Affymetrix and Invitrogen sign licensing agreement

Preliminary results from phase II studies of cocaine vaccine TA-CD

Azedra studied for treatment of neuroendocrine tumors

Advancis signs contract sales agreement with Innovex

Pierre Fabre and Millenia Hope team up

MediGene receives German grant for EndoTAG technology

Merrion and Roche collaborate on oral drug delivery feasibility study

Preclinical characterization of rivoglitazone and its effects on adiponectin in healthy subjects

Pharmacokinetics and efficacy of the DPP-IV inhibitor, PSN-9301, in patients with type 2 diabetes

Pharmacokinetics, safety and efficacy of BIM-51077 in dogs and patients with type 2 diabetes

Enrollment completed in Nebido PK study

Merck, Sharp & Dohme report on new GABA-A alpha3 modulators

Higher dose regimen of removab yields tumor response

Positive phase II results for ALTU-238 in growth hormone deficient adults

IND filing for study of VivaGel for prevention of genital herpes

deCODE updates pipeline progress

MorphoSys and Novartis expand therapeutic antibody collaboration

ANA-975 dosing suspended pending analysis of preclinical findings

Novelos' acute radiation syndrome proposal to be studied further by DHHS

Phase III Avastin study in advanced pancreatic cancer fails to meet endpoint

Highlights of dasatinib studies from the European Hematology Association meeting

Models show potential of hLF1-11 as anti-infective in stem cell transplant patients

Topical retapamulin effective in secondarily infected dermatitis

Exelon, first FDA approved treatment for Parkinson's disease dementia

Neutralizing GM-CSF shows potential to treat inflammatory diseases

Chemokine CCR5 receptor ligands for HIV patented by ViroChem Pharma

New treatment options for cardiovascular disorders reported in recent patent literature

Patent claims use of telithromycin in acute exacerbations of asthma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...